HPORx B.V. is a multinational corporation, registered in Holland NL-2020V00228 within the European Union, internationally registered with Tax identification number NL-862241133B0. We have corporate offices located in Amsterdam, Netherlands, and Administration offices located in Barcelona, Spain. We have also established branch offices and affiliates in Canada, United States, United Kingdom, Australia, and New Zealand.

We are an advertising and promotional platform for all industrial and commercial goods, products and services created from hemp. We are also a launch platform for medical therapeutic created from cannabinoid MMJ and natural sustainable products and pharmaceuticals, natural herb pharmaceutical company, pharmacy, specializing in plant-based therapeutics derived from the Hemp flower or fiber, or industrial hemp, which is a botanical class of Cannabis sativa cultivars grown specifically for industrial or medicinal use. Hemp can be used to make a wide range of products. Along with bamboo, hemp is among the fastest-growing plants on Earth.

We are also stewards of a vertical global Multivendor platform in-service to national Government licensed sanctioned and legalized medical marijuana therapeutics businesses servicing the cannabis industry and clients in the European Union, United States, Canada, Australia, New Zealand, and Great Britain.

We have launched this multi-vendor platform in service to the legally prescribed medical marijuana and cannabis business all of whom can register here if they meet all our terms and conditions to retail their own commercially licensed and government-sanctioned products goods or services derived from or prescribe from the class of Cannabis sativa cultivars grown specifically for industrial or medicinal use from hemp in each jurisdiction where it’s legal to do so.

Hemp Products Online [HPORx] B.V. does not condone the illegal use, transportation, sale to minors, or distribution in countries or jurisdictions where it is prohibited by law.

Welcome to your therapeutic specialist and marketplace!

Our organization HPORX B.V. supports plant-based derived pharmaceuticals, we support any organization engaged in the decriminalization of plant base medications. Medicinal plants have been used in healthcare since time immemorial. Studies have been carried out globally to verify their efficacy and some of the findings have led to the production of plant-based medicines. The global market value of medicinal plant products exceeds $100 billion per annum. This paper discusses the role, contributions, and usefulness of medicinal plants in tackling the diseases of public health importance, with particular emphasis on the current strategic approaches to disease prevention. A comparison is drawn between the ‘whole population’ and ‘high-risk’ strategies. The usefulness of the common-factor approach as a method of engaging other health promoters in propagating the ideals of medicinal plants is highlighted. The place of medicinal plants in preventing common diseases is further examined under the five core principles of the Primary Health Care (PHC) approach. Medicinal plants play vital roles in disease prevention and their promotion and use fit into all existing prevention strategies. However, conscious efforts need to be made to properly identify, recognize, and position medicinal plants in the design and implementation of these strategies. These approaches present interesting and emerging perspectives in the field of medicinal plants. Recommendations are proposed for strategizing the future role and place for medicinal plants in disease prevention.

REFERENCE

US National Library of Medicine

National Institutes of Health

Afr J Tradit Complement Altern Med. 2013; 10(5): 210–229. PMCID: PMC3847409

Published online 2013 Aug 12. doi: 10.4314/ajtcam.v10i5.2 PMID: 24311829